Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ACM Research Inc (ACMR) vs Axogen Inc (AXGN) Price & Performance

ACM Research Inc
Axogen Inc

Price performance

Price movement over the last 24 hours

Key statistics

ACM Research Inc vs Axogen Inc — how do they compare? ACM Research Inc trades at $97.87 (market cap $6.54B), while Axogen Inc trades at $43.04 (market cap $2.37B). The key difference: ACM Research Inc is far larger — about 2.8× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, ACM Research Inc nearer its low. Which is the better fit depends on your goals.

ACMRAXGN
Market Cap
$6.54B$2.37B
Sector
TechnologyTechnology
52-Week High
$126.89$46.19
52-Week Low
$23.92$11.28
Enterprise Value
$5.61B$2.29B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ACM Research Inc

ACMR trades at $98.52, up 0.77% today, with a bullish technical signal from moving averages and a consensus analyst price target of $110. Recent earnings showed a Q1 2026 beat but misses in prior quarters. Revenue grew to $901 million in 2025, though net income margins are under pressure. The stock has experienced volatility, with news highlighting semiconductor sector catalysts and a GF Score of 82 (GuruFocus, June 25, 2026).

Outlook is positive with 80% analyst buy ratings and semiconductor demand tailwinds, but risks include earnings inconsistency, high valuation multiples, and negative operating cash flow. Investors should weigh growth potential against execution risks in a competitive market.

Axogen Inc

AXGN trades at $45.97, up 0.17% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q1 2026 earnings of $0.07 per share, missing estimates, yet maintains a strong gross margin of 75.01%. Recent news highlights a bullish rebound and raised 2026 guidance, with 84% of analysts rating it a Buy. Support is at $44, with resistance at $47.

Outlook is cautiously optimistic due to strong analyst support and recent institutional interest, but risks include consecutive earnings misses and negative net income margins. The consensus price target of $47.60 suggests modest upside, though execution on guidance and reimbursement wins are critical for sustained growth.

Returns comparison

Trailing returns across standard periods

About ACM Research Inc

ACM Research develops and manufactures semiconductor process equipment, specializing in wafer cleaning and electroplating solutions. Its tools are used by global chipmakers to improve productivity and yield for logic and memory chips.

Read more on ACMR

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN